Attenuated vaccine-based Rabies virus SAD-P5/88 Potsdam, isolate 9509TCH

VACCINAL STRAIN


EVAg

Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
014V-01931
Attenuated vaccine-based Rabies virus SAD-P5/88 Potsdam, 9509TCH, infectivity quantified
Product Risk Group: 
Virus name: 
Isolate: 

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 vial

In stock

2 000,00 €
(Cost per access for Academics)

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
GMO: 
No
Biosafety restrictions: 
BSL3
Virus host type: 
Infectivity Test: 
Detection of Fluorescence Focus Units in N2a cell-line
Viral titer: 
6.8 10e8 FFU/ml
Production cell line: 
Virus Cultivability: 
Shipping conditions: 
IATA Classification: 

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Wednesday, 15 February, 1995
Country of collection: 
Suspected epidemiological origin : 










Comments (1)

  • mbahrami's picture

    Dear EVAg,
    On behalf of Gabian group, I would appreciate if you could answer our questions about "Attenuated vaccine-based Rabies virus SAD-P5/88 Potsdam, isolate 9509TCH".
    First of all, is the type of mentioned vaccine, potentially infectious for human or animal?
    In addition, I want to know more about immunogenicity of it for human and animal. As we are going to develop rabies vaccine for dog and cat, I would like to know about its effectiveness in case of cell culture also.

    Sincerely yours,

    Dr. Mohammad Bahrami
    Veterinary Medicine
    PhD Biomolecular Technology
    Shidmehr Gabian Group
    Chief Executive Officer
    No. 5, 13th Alley, Ahmad Ghasir Ave.
    (Bokharest) Tehran - Iran.
    Tel: (+98 21) 88 70 1600, Ext. 2672
    Mobile: (+98) 913 318 13 80
    Email: Shidmehr.gabian@gmail.com

    May 27, 2022